Means lower Emerging observational studies and small interventional trials suggest that GLP-1 RAs may be used in patients with advanced CKD with preserved glucose-lowering efficacy and a relatively low intrinsic risk of hypoglycemia compared with insulin and sulfonylureas ( Semaglutide has recently received expanded regulatory approval for use in patients with T2DM and CKD, reflecting growing confidence in its renal safety profile and potential kidney-protective benefits ( In Saudi Arabia, T2DM prevalence is among the highest worldwide and is accompanied by high rates of obesity, cardiovascular disease, and CKD ( Therefore, this multicenter retrospective study aimed to evaluate the real-world safety and effectiveness of semaglutide in patients with ESRD receiving care at Saudi tertiary healthcare centers, with a focus on glycemic outcomes, body weight changes, cardiovascular events, renal safety, and treatment tolerability

Unlike fad diets or onesizefitsall plans, this physicianguided approach focuses on your metabolic health, medical history, and unique goals so you can achieve meaningful, sustainable change
Some patients experiencing significant weight loss may notice changes in skin texture or elasticity, but these are generally related to the weight loss itself rather than a direct medication effect
Contact us today to schedule your consultation with the renowned San Antonio plastic surgeon and breast & body specialist Dr